Graph-Based Gene Encoders

• Graph-based gene encoders are advanced neural frameworks that model genes and regulatory elements as nodes and edges to capture complex biological interactions.
• They integrate modalities using techniques like GNNs, auto-encoders, and diffusion modules to support tasks such as gene regulatory network inference and variant assembly.
• Empirical evaluations show these encoders offer improved prediction accuracy and robustness in applications like haplotype assembly and single-cell analysis.

Graph-based gene encoders are neural architectures or algorithmic frameworks that model genes, regulatory modules, or genomic sequences as nodes (and relations as edges) in a graph structure, encoding both topological dependencies and multimodal biological information into low-dimensional vector representations. These encoders leverage the expressive power of graph neural networks (GNNs), graph auto-encoders, message passing, or graph-diffusion modules, and are widely used for tasks including gene function prediction, gene regulatory network (GRN) inference, gene expression imputation, disease-gene prioritization, essentiality prediction, and variant/haplotype assembly. The category includes both end-to-end frameworks for specific biological applications and compositional modules that inject graph-based inductive biases into broader genomic machine learning pipelines.

1. Foundational Models and Mathematical Principles

Graph-based gene encoders are built upon the mathematical formalism of graphs $G = (V, E)$ (with $V$ as gene/protein/SNP/k-mer nodes and $E$ as interaction or alignment edges), possibly extended to bipartite, heterogeneous, or multi-relational contexts. Typical encoders operate over:

• Adjacency matrix $A \in \mathbb{R}^{N \times N}$ for homogeneous gene-gene/protein-protein or generalized interaction graphs, or higher-order adjacency tensors for multi-type/multi-modality integration (Schapke et al., 2020, Chi et al., 6 May 2025).
• Node features $X \in \mathbb{R}^{N \times d}$, incorporating expression data, sequence embeddings, multi-omics or pretrained LLM projections (Chi et al., 6 May 2025).
• Graph neural network (GNN) message passing: A prototypical update for each node in a GCN/GAT layer is

$$h_i^{(l+1)} = \sigma \left( \sum_{j \in \mathcal{N}(i)} \alpha_{ij} W h_j^{(l)} \right)$$

where $\alpha_{ij}$ are edge (possibly attention-based) weights (Schapke et al., 2020, Kapuśniak et al., 2023).

• Variational or auto-encoding objective: learning probabilistic node embeddings via an ELBO as in a Variational Graph Auto-Encoder (VGAE) (Singh et al., 2019).

Problem-specific graph structures (e.g., bipartite read-SNP graphs (Ke et al., 2019), gene-drug tripartite networks (Wu et al., 13 Feb 2025), or De Bruijn sequence graphs (Kapuśniak et al., 2023)) are constructed to directly reflect biological phenomena and constraints.

2. Encoder Architectures and Augmentation Schemes

Encoders vary by biological context, graph type, and learning objective:

• Haplotype/virotype graph auto-encoders: GAEseq (Ke et al., 2019) forms a bipartite graph combining read nodes $A$ and SNP nodes $B$, using alternating read-SNP message passing layers. The per-nucleotide edge-typed convolutional layers yield soft posterior assignments for latent read origins, which are then aggregated to reconstruct haplotypes with minimal error correction score (MEC).
• Contrastive learning on GRNs: SupGCL (Oshima et al., 23 May 2025) integrates patient- and perturbation-specific GRNs, augmenting with biologically meaningful knockdowns, and jointly optimizing node-level and augmentation-level contrastive losses. Teacher GRNs derived from real knockdown experiments serve as supervision signals, aligning encoder representations with experimentally-observed regulatory rewiring.
• Multi-modal/fusion-based HGNNs: GRAPE (Chi et al., 6 May 2025) initializes node representations with concatenated BERT-based textual and HyenaDNA sequence embeddings, aligned via contrastive objective, then refined via a heterogeneous GAT factoring in biotype (coding/non-coding) edge classes. Graph structure learning (GSL) is dynamically performed.
• Graph-diffusion transformers: GenoHoption (Cheng et al., 2024) introduces parameter-free graph-diffusion operators—such as personalized PageRank or heat-kernel propagation—as a lightweight substitute for full self-attention, expanding the receptive field without introducing parameter explosion.

Augmentation strategies may be non-biological (random edge/node drop), structural (biased-walks, sub-kmer similarities (Kapuśniak et al., 2023)), or biological (gene knockdown masking (Oshima et al., 23 May 2025, Chi et al., 6 May 2025)), the latter often preferred for aligning representations with true biological perturbation semantics.

3. Application Domains and Task-Specific Adaptations

Graph-based gene encoders underpin a spectrum of genomic and biomedical tasks, including but not limited to:

Task	Example Model(s)	Biological Graph Type
Haplotype/quasispecies assembly	GAEseq (Ke et al., 2019)	Bipartite read–SNP graph
GRN inference	GT-GRN (Teji et al., 23 Apr 2025), GRAPE (Chi et al., 6 May 2025)	Weighted/multi-modal gene networks
Sequence embedding	Kapuśniak et al. (Kapuśniak et al., 2023), GFAE (Hasibi et al., 2020)	De Bruijn/context/structural similarity
Drug-gene prediction	GDNDGP (Wu et al., 13 Feb 2025)	Meta-path homogeneous/heterogeneous
Gene essentiality prediction	EPGAT (Schapke et al., 2020)	PPI (multiomics-labeled)
Single-cell analysis	GenoHoption (Cheng et al., 2024)	Co-expression and regulatory networks

These encoders are instantiated with architecture and loss tailored to the target: e.g., hard negative mining via diffusion for robust drug–gene disentanglement (Wu et al., 13 Feb 2025), consensus-based haplotype decoding minimizing MEC (Ke et al., 2019), and multi-modal fusion for capturing gene biotype-dependent interactions (Chi et al., 6 May 2025).

4. Evaluation and Benchmarking

Empirical assessments consistently benchmark graph-based gene encoders against classical graph theoretic measures, shallow machine learning, and random-walk/embedding methods (e.g., node2vec, DeepWalk):

• GAEseq achieves an MEC ≈8.2 and CPR ≈0.822 at 15× coverage, outperforming HapCompass and AltHap on both synthetic and experimental datasets (Ke et al., 2019).
• SupGCL yields higher hazard prediction C-index (0.698±0.085 colorectal) and breast cancer subtype accuracy (0.847±0.036) than best unsupervised GCLs (Oshima et al., 23 May 2025).
• EPGAT delivers AUCs between 0.78 and 0.97, surpassing degree-based and node2vec-MLP baselines across organisms (Schapke et al., 2020).
• GDNDGP increases hit rates by leveraging parallel diffusion for hard negative sample generation in drug–gene prediction (Wu et al., 13 Feb 2025).
• GFAE achieves lower imputation MSE than MLP or MAGIC in single-cell RNA-seq contexts (Hasibi et al., 2020).

Experimental designs include ablation analysis (impact of modality inclusion and edge type), varying graph density, and robustness to label imbalance or sample scarcity.

5. Limitations and Future Directions

• Graph structure dependence: Performance is highly sensitive to the biological relevance and accuracy of input graphs (GeneMania outperforms RegNetwork; edge density alone is not sufficient) (Dutil et al., 2018).
• Edge semantics: Most approaches either treat edges as untyped or aggregate multiple relations indiscriminately; incorporation of directed, signed, or functionally-specific links is an open area (Dutil et al., 2018, Chi et al., 6 May 2025).
• Computational scalability: All-pairs similarity computation (e.g., sub-kmer cosine) is quadratic in node count; future designs may leverage thresholding, ANN, or scalable attention mechanisms (Kapuśniak et al., 2023).
• Modality and task-agnostic fusion: Integrating global context (BERT, random-walks), local dynamics (GAT, GCN), and positional encoding (Laplacian eigenspectrum) can further enhance biological interpretability and performance (Teji et al., 23 Apr 2025).
• Extension to multiplex/multi-relation graphs: The extension to graphs encoding protein–protein, gene–disease, and gene–drug interactions jointly (multiplex architecture) is a suggested direction (Singh et al., 2019).

A plausible implication is that as large-scale single-cell and multi-omics datasets proliferate, flexible, biomedically-grounded graph-based gene encoders that unify domain knowledge (knockdown, regulatory topology), pretraining on foundational models, and efficient message-passing will become central to interpretable, accurate biological discovery pipelines.

6. Relevance and Impact in Genomics and Systems Biology

Graph-based gene encoders have supplanted or outperformed traditional centrality-driven or tabular ML approaches by learning distributed, task-specialized representations informed by both network structure and multimodal data. They have become crucial:

• As plug-in modules for single-cell foundation models, efficiently supplying network priors and improving annotation/perturbation prediction with minimal parameter overhead (Cheng et al., 2024);
• For robust imputation, disease gene prioritization, and functional inference in both low-data and large-scale settings (Hasibi et al., 2020, Oshima et al., 23 May 2025);
• As interpretable frameworks, where attention or consensus readout mechanisms downweight unreliable edges and expose driver interactions (Schapke et al., 2020, Ke et al., 2019).

This suggests that graph-based gene encoders will continue to be central in multi-modal genomics workflows, cross-task transfer, and systematic integration of experimental perturbation and prior biological knowledge.